Enclomiphene for Men: Studies and Label Warnings
Studies of Enclomiphene that enrolled only men, what they measured, and what is still unproven.
- Strongest evidence
- Human RCT
- Studies enrolling only men
- 7
- in our evidence file (PubMed search, 11 Oct 2026)
- FDA status
- Not approved
Studies that enrolled only men
Each row is a study whose participants were described as men only. Results from one sex are not evidence for the other. Studies of animals and cells are not included.
| Study | Design | Population | Dose | First outcome |
|---|---|---|---|---|
| BJU international 2016, PMID 26496621 | Human RCT | Overweight men aged 18-60 with secondary hypogonadism (two parallel phase III studies, ZA-304 and ZA-305) | two doses of enclomiphene citrate vs testosterone gel (AndroGel 1.62%) | Total testosterone: Total testosterone rose from baseline at 16 weeks in all groups, including enclomiphene. |
| Fertility and sterility 2014, PMID 25044085 | Human RCT | Men with secondary hypogonadism (phase II) | Not stated | Testosterone, LH, sperm: Enclomiphene raised morning testosterone, estradiol and LH similarly to topical gel; sperm counts conserved. |
| The journal of sexual medicine 2013, PMID 23530575 | Human RCT | Men with secondary hypogonadism previously treated with topical testosterone (phase IIB, open-label) | Not stated | Total testosterone at 6 months: At 6 months total testosterone was 545 (gel) and 525 (enclomiphene) pg/dL. |
| BJU international 2013, PMID 23875626 | Human RCT | Men with secondary hypogonadism (phase II; 44 completed per protocol) | 6.25, 12.5 or 25 mg | Total testosterone at day 42: At 25 mg daily, day-42 testosterone averaged 604 ng/dL versus 500 ng for transdermal testosterone. |
| Translational andrology and urology 2024, PMID 39434750 | Human observational | Men at one academic centre switched from clomiphene to enclomiphene (retrospective) | Not stated | Median testosterone change: Median testosterone increase was 166 with enclomiphene versus 98 ng/dL with clomiphene (P=0.20, not significant). |
| Archives of endocrinology and metabolism 2025, PMID 41066380 | Meta-analysis | Men with functional hypogonadism; RCTs of clomiphene or enclomiphene vs placebo, T gel or hCG | Not stated | Total testosterone vs placebo: SERMs (clomiphene or enclomiphene) raised total testosterone by a mean 273.76 ng/dL versus placebo, with high heterogeneity (I2 = 89%). |
| Andrology 2023, PMID 36604313 | Meta-analysis | Men with obesity-related functional androgen deficiency, 7 studies | enclomiphene citrate 12.5-25 mg daily; clomiphene 12.5-50 mg daily | Testosterone with enclomiphene: Pooled testosterone rose by a mean 7.50 nmol/L with enclomiphene (and 11.56 nmol/L with clomiphene). |
Peptides studied in men, compared
How strong is it?
A human randomized trial outweighs any number of animal studies. Animal and cell results show a mechanism worth testing, not that it works in people.
Why this page covers men only
MedlinePlus lists low testosterone among the conditions that only affect men.[13]
Studies that enrolled only men
The two phase III trials enrolled overweight men aged 18-60 with secondary hypogonadism and compared two enclomiphene doses with testosterone gel.[1]
The phase II dose study enrolled forty-eight men with low total testosterone and tested three enclomiphene doses against transdermal testosterone.[4]
A proof-of-principle study of 12 men with secondary hypogonadism who had been on topical testosterone found testosterone and sperm counts rose with enclomiphene.[3]
A pooled analysis of obesity-related androgen deficiency covered 292 men given clomiphene or enclomiphene daily for 1.5-4 months.[7]
A retrospective review of 66 patients switched from clomiphene to enclomiphene and found lower estradiol change and fewer reported adverse effects.[5]
Safety findings in these men
The pooled obesity-related analysis registered no treatment-related unexpected findings regarding safety.[7]
The 66-patient review found decreased libido, reduced energy and mood changes significantly less frequent on enclomiphene than clomiphene.[5]
No data for women
Every cited enclomiphene study enrolled men (for example, men with secondary hypogonadism); none of these results can be applied to women.[2]
Other peptides people research for men
All peptides for men, comparedCommon questions
Has Enclomiphene been studied in men?
7 studies we summarise enrolled only men. Results from one sex are not evidence for the other.
Is enclomiphene approved for men?
Not in the register lookup: Drugs@FDA returned no match on 2026-10-02.[14]
More on Enclomiphene
Sources
- 1Oral enclomiphene citrate raises testosterone and preserves sperm counts in obese hypogonadal men, unlike topical testosterone: restoration instead of replacement.BJU international · 2016PMID 26496621Accessed 2 Oct 2026
- 2Enclomiphene citrate stimulates testosterone production while preventing oligospermia: a randomized phase II clinical trial comparing topical testosterone.Fertility and sterility · 2014PMID 25044085Accessed 2 Oct 2026
- 3Oral enclomiphene citrate stimulates the endogenous production of testosterone and sperm counts in men with low testosterone: comparison with testosterone gel.The journal of sexual medicine · 2013PMID 23530575Accessed 2 Oct 2026
- 4Testosterone Restoration by Enclomiphene Citrate in Men with Secondary Hypogonadism: Pharmacodynamics and Pharmacokinetics.BJU international · 2013PMID 23875626Accessed 2 Oct 2026
- 5Safety and efficacy of enclomiphene and clomiphene for hypogonadal men.Translational andrology and urology · 2024PMID 39434750Accessed 2 Oct 2026
- 6Clomiphene or enclomiphene citrate for the treatment of male hypogonadism: a systematic review and meta-analysis of randomized controlled trials.Archives of endocrinology and metabolism · 2025PMID 41066380Accessed 2 Oct 2026
- 7Selective modulation of estrogen receptor in obese men with androgen deficiency: A systematic review and meta-analysis.Andrology · 2023PMID 36604313Accessed 2 Oct 2026
- 8PubMed search: enclomiphene[tiab] OR enclomifene[tiab] OR "trans-clomiphene"[tiab] (98 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 9PubMed search: (enclomiphene[tiab] OR enclomifene[tiab]) AND (randomized controlled trial[pt] OR clinical trial[pt] OR meta-analysis[pt]) (9 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 10PubMed search: (enclomiphene[tiab] OR enclomifene[tiab]) AND (hypogonadism[tiab] OR testosterone[tiab]) AND humans[mh] (17 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 11PubMed search: (enclomiphene[tiab] OR enclomifene[tiab]) AND (half-life[tiab] OR pharmacokinetic*[tiab]) (5 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 12PubMed search: enclomiphene[tiab] OR enclomifene[tiab] OR Androxal[tiab] AND (adverse[tiab] OR "side effect*"[tiab] OR safety[tiab] OR tolerab*[tiab] OR toxicity[tiab] OR "case report"[pt]) (17 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 11 Oct 2026
- 13Official web pageOfficial web page · web page
- 14Drugs@FDA (openFDA) search: active ingredient "enclomiphene"U.S. Food and Drug Administration · 2026api.fda.govAccessed 2 Oct 2026
Found an error? Report a correction.